Add to ORKGAspirin In Primary Cardiovascular Disease Prevention In Type-2 Diabetic Patients: A Longitudinal Observational Study
© 2020 Springer Nature Switzerland AG. Part of Springer Nature.The use of aspirin, while well establ...
Primary prevention of cardiovascular events with aspirin in patients with elevated cardiovascular ri...
Aspirin is the most commonly used medication worldwide. Beside its well-known anti-inflammatory effe...
AbstractAspirin reduces vascular death by approximately 15% and nonfatal vascular events by about 30...
There is strong evidence supporting the use of low-dose aspirin in the secondary prevention of cardi...
Although the improved control of hyperglycaemia and other cardiovascular risk factors was associated...
Diabetes mellitus markedly increases the risk of cardiovascular diseases, with an especially elevate...
The risk-to-benefit ratio for the use of low dose of aspirin in primary cardiovascular (CV) preventi...
The risk-to-benefit ratio for the use of low dose of aspirin in primary cardiovascular (CV) preventi...
In the first of this thesis, results are summarized of a randomised crossover trial on the effects o...
Aspirin is effective for the prevention of cardiovascular events in patients with a history of vascu...
Abstract Background This study was conducted in order to determine the use of aspirin and to assess ...
Aspirin use for the primary prevention of cardiovascular disease should be targeted to patients with...
The POPADAD (Prevention Of Progression of Arterial Disease And Diabetes) study did not show a benefi...
The burden of cardiovascular disease (CVD) among patientswith diabetes is substantial. Individuals w...
© 2020 Springer Nature Switzerland AG. Part of Springer Nature.The use of aspirin, while well establ...
Primary prevention of cardiovascular events with aspirin in patients with elevated cardiovascular ri...
Aspirin is the most commonly used medication worldwide. Beside its well-known anti-inflammatory effe...
AbstractAspirin reduces vascular death by approximately 15% and nonfatal vascular events by about 30...
There is strong evidence supporting the use of low-dose aspirin in the secondary prevention of cardi...
Although the improved control of hyperglycaemia and other cardiovascular risk factors was associated...
Diabetes mellitus markedly increases the risk of cardiovascular diseases, with an especially elevate...
The risk-to-benefit ratio for the use of low dose of aspirin in primary cardiovascular (CV) preventi...
The risk-to-benefit ratio for the use of low dose of aspirin in primary cardiovascular (CV) preventi...
In the first of this thesis, results are summarized of a randomised crossover trial on the effects o...
Aspirin is effective for the prevention of cardiovascular events in patients with a history of vascu...
Abstract Background This study was conducted in order to determine the use of aspirin and to assess ...
Aspirin use for the primary prevention of cardiovascular disease should be targeted to patients with...
The POPADAD (Prevention Of Progression of Arterial Disease And Diabetes) study did not show a benefi...
The burden of cardiovascular disease (CVD) among patientswith diabetes is substantial. Individuals w...
© 2020 Springer Nature Switzerland AG. Part of Springer Nature.The use of aspirin, while well establ...
Primary prevention of cardiovascular events with aspirin in patients with elevated cardiovascular ri...
Aspirin is the most commonly used medication worldwide. Beside its well-known anti-inflammatory effe...